Dr. Mario Sznol
Claim this profileYale University
Studies Melanoma
Studies Solid Tumors
7 reported clinical trials
12 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
BRAF positive
2Solid Tumors
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Mario Sznol is currently running
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting1 award Phase 2
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Mario Sznol
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mario Sznol has experience with
- Pembrolizumab
- Nivolumab
- Cemiplimab
- DF6002
- VV1
- E-602
Breakdown of trials Mario Sznol has run
Melanoma
Solid Tumors
Skin Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mario Sznol specialize in?
Mario Sznol focuses on Melanoma and Solid Tumors. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Mario Sznol currently recruiting for clinical trials?
Yes, Mario Sznol is currently recruiting for 4 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Mario Sznol has studied deeply?
Yes, Mario Sznol has studied treatments such as Pembrolizumab, Nivolumab, Cemiplimab.
What is the best way to schedule an appointment with Mario Sznol?
Apply for one of the trials that Mario Sznol is conducting.
What is the office address of Mario Sznol?
The office of Mario Sznol is located at: Yale University, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.